Concepts (171)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Virus Latency | 4 | 2018 | 251 | 0.85 | Why? |
| Antibody-Dependent Cell Cytotoxicity | 2 | 2021 | 349 | 0.76 | Why? |
| HIV-1 | 7 | 2018 | 3365 | 0.73 | Why? |
| HIV Envelope Protein gp41 | 1 | 2017 | 153 | 0.61 | Why? |
| HIV Envelope Protein gp120 | 1 | 2017 | 267 | 0.56 | Why? |
| HIV Antibodies | 2 | 2018 | 776 | 0.54 | Why? |
| Antibodies, Viral | 12 | 2021 | 51949 | 0.27 | Why? |
| CD40 Antigens | 1 | 2021 | 118 | 0.22 | Why? |
| HIV Infections | 6 | 2018 | 11620 | 0.22 | Why? |
| Mucociliary Clearance | 1 | 2021 | 72 | 0.22 | Why? |
| Antibodies, Neutralizing | 8 | 2021 | 25288 | 0.21 | Why? |
| Cilia | 1 | 2021 | 183 | 0.21 | Why? |
| Lymphopoiesis | 1 | 2019 | 26 | 0.20 | Why? |
| Cell Fusion | 2 | 2020 | 400 | 0.20 | Why? |
| Spike Glycoprotein, Coronavirus | 9 | 2021 | 37182 | 0.20 | Why? |
| Antigen-Antibody Reactions | 1 | 2021 | 616 | 0.19 | Why? |
| Receptors, HIV | 1 | 2017 | 15 | 0.18 | Why? |
| Serologic Tests | 3 | 2021 | 4359 | 0.18 | Why? |
| Giant Cells | 1 | 2020 | 334 | 0.18 | Why? |
| Vacuoles | 1 | 2017 | 36 | 0.17 | Why? |
| HIV Core Protein p24 | 1 | 2017 | 48 | 0.17 | Why? |
| Complement System Proteins | 1 | 2021 | 380 | 0.17 | Why? |
| Proviruses | 1 | 2017 | 82 | 0.16 | Why? |
| Simian Acquired Immunodeficiency Syndrome | 1 | 2018 | 154 | 0.16 | Why? |
| Immunity, Humoral | 2 | 2021 | 4849 | 0.16 | Why? |
| CD4 Antigens | 1 | 2017 | 306 | 0.15 | Why? |
| Biomarkers | 2 | 2020 | 23361 | 0.15 | Why? |
| Convalescence | 3 | 2021 | 2829 | 0.15 | Why? |
| T-Lymphocytes | 4 | 2021 | 6670 | 0.15 | Why? |
| Neutralization Tests | 4 | 2021 | 6698 | 0.15 | Why? |
| Cytopathogenic Effect, Viral | 1 | 2017 | 635 | 0.14 | Why? |
| Mice, Transgenic | 2 | 2019 | 2739 | 0.14 | Why? |
| Astrocytes | 1 | 2017 | 298 | 0.14 | Why? |
| Cell Death | 1 | 2017 | 536 | 0.14 | Why? |
| Cells, Cultured | 4 | 2017 | 5835 | 0.13 | Why? |
| Immune Evasion | 2 | 2021 | 2081 | 0.13 | Why? |
| Sex Characteristics | 1 | 2021 | 1120 | 0.13 | Why? |
| Receptors, IgG | 1 | 2017 | 578 | 0.13 | Why? |
| Fibroblasts | 1 | 2017 | 839 | 0.12 | Why? |
| Virology | 1 | 2017 | 489 | 0.12 | Why? |
| Virus Activation | 1 | 2017 | 480 | 0.12 | Why? |
| Immunoglobulin A | 2 | 2021 | 3567 | 0.12 | Why? |
| Epitopes | 2 | 2021 | 4113 | 0.11 | Why? |
| Lymph Nodes | 1 | 2018 | 1060 | 0.11 | Why? |
| Killer Cells, Natural | 1 | 2021 | 2093 | 0.11 | Why? |
| T-Lymphocyte Subsets | 1 | 2018 | 1387 | 0.11 | Why? |
| Melanoma | 1 | 2021 | 1229 | 0.10 | Why? |
| Taste Disorders | 1 | 2021 | 1720 | 0.10 | Why? |
| Virus Replication | 4 | 2021 | 14331 | 0.10 | Why? |
| Disease Reservoirs | 1 | 2018 | 1672 | 0.09 | Why? |
| Epithelial Cells | 2 | 2021 | 3508 | 0.09 | Why? |
| Dendritic Cells | 1 | 2017 | 1330 | 0.09 | Why? |
| Asymptomatic Diseases | 1 | 2021 | 3444 | 0.09 | Why? |
| CD4-Positive T-Lymphocytes | 3 | 2018 | 4545 | 0.09 | Why? |
| France | 5 | 2021 | 12074 | 0.09 | Why? |
| Interferon-gamma | 1 | 2018 | 2711 | 0.09 | Why? |
| Gene Expression | 1 | 2018 | 3332 | 0.08 | Why? |
| Immunoglobulin G | 5 | 2021 | 21571 | 0.08 | Why? |
| Interferon Type I | 1 | 2018 | 2789 | 0.07 | Why? |
| Zika Virus | 1 | 2017 | 1924 | 0.07 | Why? |
| Animals | 8 | 2021 | 78931 | 0.07 | Why? |
| Host-Pathogen Interactions | 2 | 2020 | 11041 | 0.06 | Why? |
| Kinetics | 2 | 2021 | 3238 | 0.06 | Why? |
| Olfaction Disorders | 1 | 2021 | 3704 | 0.06 | Why? |
| Axoneme | 1 | 2021 | 25 | 0.06 | Why? |
| Basal Bodies | 1 | 2021 | 26 | 0.06 | Why? |
| Humans | 25 | 2021 | 930598 | 0.06 | Why? |
| HEK293 Cells | 3 | 2021 | 8394 | 0.06 | Why? |
| RNA-Binding Proteins | 2 | 2020 | 1022 | 0.06 | Why? |
| Antigen-Presenting Cells | 1 | 2021 | 206 | 0.05 | Why? |
| Disease Models, Animal | 1 | 2019 | 10998 | 0.05 | Why? |
| B-Lymphocytes | 3 | 2021 | 4418 | 0.05 | Why? |
| Forkhead Transcription Factors | 1 | 2021 | 231 | 0.05 | Why? |
| HLA-DR2 Antigen | 1 | 2019 | 3 | 0.05 | Why? |
| Macaca | 1 | 2021 | 388 | 0.05 | Why? |
| Immunoprecipitation | 1 | 2020 | 300 | 0.05 | Why? |
| Interleukin Receptor Common gamma Subunit | 1 | 2018 | 24 | 0.05 | Why? |
| Antigens, Differentiation | 1 | 2020 | 172 | 0.05 | Why? |
| Luciferases | 1 | 2020 | 378 | 0.05 | Why? |
| Synapses | 1 | 2018 | 83 | 0.05 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.05 | Why? |
| HLA-A2 Antigen | 1 | 2019 | 134 | 0.05 | Why? |
| Membrane Proteins | 2 | 2020 | 1733 | 0.05 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.05 | Why? |
| Immunoglobulin Class Switching | 1 | 2018 | 133 | 0.04 | Why? |
| SEC Translocation Channels | 1 | 2017 | 6 | 0.04 | Why? |
| Male | 11 | 2021 | 367725 | 0.04 | Why? |
| Young Adult | 4 | 2021 | 93724 | 0.04 | Why? |
| Mice, Inbred BALB C | 2 | 2019 | 5814 | 0.04 | Why? |
| Antibodies, Monoclonal | 1 | 2017 | 8041 | 0.04 | Why? |
| Adult | 8 | 2021 | 244371 | 0.04 | Why? |
| Cell Division | 1 | 2017 | 136 | 0.04 | Why? |
| Antibody Specificity | 1 | 2021 | 1328 | 0.04 | Why? |
| Health Personnel | 3 | 2021 | 29646 | 0.04 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.04 | Why? |
| Mesocricetus | 1 | 2021 | 1847 | 0.04 | Why? |
| Mice | 3 | 2021 | 21357 | 0.04 | Why? |
| Female | 9 | 2021 | 380317 | 0.04 | Why? |
| Longitudinal Studies | 2 | 2021 | 9893 | 0.04 | Why? |
| Simian Immunodeficiency Virus | 1 | 2018 | 251 | 0.04 | Why? |
| Cell Separation | 1 | 2017 | 270 | 0.04 | Why? |
| Vaccines, Subunit | 1 | 2021 | 1088 | 0.04 | Why? |
| Seroepidemiologic Studies | 2 | 2021 | 10017 | 0.04 | Why? |
| Phosphatidylinositol 3-Kinases | 1 | 2017 | 347 | 0.04 | Why? |
| env Gene Products, Human Immunodeficiency Virus | 1 | 2018 | 386 | 0.04 | Why? |
| Sensitivity and Specificity | 3 | 2021 | 22971 | 0.04 | Why? |
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 372 | 0.03 | Why? |
| Healthy Volunteers | 1 | 2020 | 1444 | 0.03 | Why? |
| Endoplasmic Reticulum | 1 | 2017 | 430 | 0.03 | Why? |
| Toll-Like Receptor 7 | 1 | 2017 | 402 | 0.03 | Why? |
| Cricetinae | 1 | 2021 | 3344 | 0.03 | Why? |
| Immunoglobulin M | 2 | 2021 | 9091 | 0.03 | Why? |
| Time Factors | 3 | 2021 | 31397 | 0.03 | Why? |
| Macaca fascicularis | 1 | 2018 | 1009 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Mice, Knockout | 1 | 2018 | 1815 | 0.03 | Why? |
| Models, Immunological | 1 | 2018 | 727 | 0.03 | Why? |
| Cell Differentiation | 1 | 2019 | 1338 | 0.03 | Why? |
| Respiratory Mucosa | 1 | 2021 | 1522 | 0.03 | Why? |
| Cell Line, Tumor | 1 | 2021 | 3608 | 0.03 | Why? |
| Flow Cytometry | 1 | 2020 | 2393 | 0.03 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2020 | 2309 | 0.03 | Why? |
| Lymphocyte Activation | 1 | 2021 | 2742 | 0.03 | Why? |
| Phosphoproteins | 1 | 2021 | 4346 | 0.03 | Why? |
| Adaptive Immunity | 1 | 2021 | 2585 | 0.02 | Why? |
| Cross Reactions | 1 | 2021 | 4374 | 0.02 | Why? |
| Immunologic Memory | 1 | 2021 | 3362 | 0.02 | Why? |
| Up-Regulation | 1 | 2017 | 2249 | 0.02 | Why? |
| Protein Domains | 1 | 2021 | 6563 | 0.02 | Why? |
| Binding Sites | 1 | 2021 | 6201 | 0.02 | Why? |
| Antibody Formation | 1 | 2021 | 4038 | 0.02 | Why? |
| Cytokines | 2 | 2021 | 15010 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2018 | 5542 | 0.02 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.02 | Why? |
| DNA, Viral | 1 | 2017 | 2521 | 0.02 | Why? |
| Macrophages | 1 | 2018 | 2784 | 0.02 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.02 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2017 | 3788 | 0.02 | Why? |
| Schools | 1 | 2021 | 4187 | 0.02 | Why? |
| Cell Line | 1 | 2020 | 12040 | 0.02 | Why? |
| Acute Disease | 1 | 2018 | 6029 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.02 | Why? |
| Serine Endopeptidases | 1 | 2020 | 4606 | 0.02 | Why? |
| Transcriptome | 1 | 2018 | 3466 | 0.02 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2021 | 5837 | 0.02 | Why? |
| Anti-HIV Agents | 1 | 2017 | 2209 | 0.02 | Why? |
| Saliva | 1 | 2020 | 4679 | 0.02 | Why? |
| Protein Binding | 1 | 2021 | 11430 | 0.02 | Why? |
| Receptors, Virus | 1 | 2021 | 5659 | 0.02 | Why? |
| Vero Cells | 1 | 2020 | 14117 | 0.02 | Why? |
| India | 1 | 2021 | 11875 | 0.02 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.02 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Case-Control Studies | 1 | 2020 | 17671 | 0.01 | Why? |
| Child | 2 | 2021 | 70012 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Mutation | 1 | 2021 | 12376 | 0.01 | Why? |
| Models, Biological | 1 | 2018 | 4907 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.01 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.01 | Why? |
| Signal Transduction | 1 | 2017 | 7207 | 0.01 | Why? |
| Aged | 3 | 2021 | 215776 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 9335 | 0.01 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.01 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.01 | Why? |
| Lung | 1 | 2021 | 31049 | 0.01 | Why? |
| Risk Factors | 1 | 2021 | 71621 | 0.01 | Why? |
| Pandemics | 2 | 2020 | 389249 | 0.00 | Why? |
Bruel's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(171)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(270)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_